
|Articles|November 15, 2016
Tufts CSDD Reports Promising Outlook on Pediatrics
A new analysis conducted by the Tufts Center for the Study of Drug Development reports that the outlook for greater pediatric drug development is promising.
Advertisement
A new analysis conducted by the Tufts Center for the Study of Drug Development reports that the outlook for greater pediatric drug development is promising. Though R&D complexity has grown more than 50% since 2008, resources dedicated to pediatric studies have increased across most R&D functions.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AI-Driven Clinical Trial Recruitment and Design
2
What Clinical Trials Can Learn from the Gig Economy About Payments
3
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
4
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
5




